Importance of monocyte deactivation in determining early outcome after ventricular assist device implantation

International Journal of Artificial Organs

Volumn 35, Issue 3, 2012, Pages 169-176

  Kirsch, Matthias ^a   Boval, Bernadette ^b   Damy, Thibaud ^a   Ghendouz, Soulef ^a   Vermes, Emmanuelle ^a   Loisance, Daniel ^a   Drouet, Ludovic ^b  

^a HENRI MONDOR HOSPITAL   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

Author keywords

HLA DR; Mechanical circulatory support; Monocytes; Outcome; Ventricular assist device

Indexed keywords

BODY FLUIDS; FIBER OPTIC SENSORS; PATIENT REHABILITATION; REGRESSION ANALYSIS;

ANTI-INFLAMMATORY RESPONSE; HAEMODYNAMICS; HLA-DR; HUMAN LEUKOCYTE ANTIGEN; MECHANICAL CIRCULATORY SUPPORT; MONOCYTE; OUTCOME; POST-OPERATIVE DAYS; PROINFLAMMATORY RESPONSE; VENTRICULAR ASSIST DEVICE;

INTENSIVE CARE UNITS;

ASPARTATE AMINOTRANSFERASE; HLA ANTIGEN; MONOCYTIC HUMAN LEUKOCYTE ANTIGEN DR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL EVALUATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEVICE INFECTION; FEMALE; FLOW CYTOMETRY; HOSPITALIZATION; HUMAN; IMPLANTATION; INTENSIVE CARE UNIT; LEFT VENTRICULAR ASSIST DEVICE; MALE; MULTIPLE REGRESSION; POSTOPERATIVE PERIOD; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; SURGICAL MORTALITY; TREATMENT OUTCOME;

EID: 84862752167     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/ijao.5000053     Document Type: Article

References (21)

1. Hampton CR, Verrier E. Systemic consequences of ventricular assist devices: alterations of coagulation, immune function, inflammation, and the neuroendocrine system. Artif Organs. 2002;26:902-908. Medline. doi:10.1046/j.1525-1594.2002.07122.x
2. Thompson LO, Loebe M, Noon GP. What price support? Ventricular assist device induced systemic response. ASAIO J. 2003;49:518-526. Medline. doi:10.1097/01. MAT.0000085672.42122.49
3. Baufreton C, Kirsch M, Loisance DY. Measures to control blood activation during assisted circulation. Ann Thorac Surg. 1998;66:1837-1844. Medline. doi:10.1016/S0003-4975(98)00726-7
4. Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med. 1996;24:1125-1128. Medline. doi:10.1097/00003246-199607000-00010
5. Ward NS, Casserly B, Ayala A. The compensatory antiinflammatory response syndrome (CARS) in critically ill patients. Clin Chest Med. 2008;29:617-625. Medline. doi:10.1016/j.ccm.2008.06.010
6. Haveman JW, Muller Kobold AC, Cohen Tervaert JW, et al. The central role of monocytes in the pathogenesis of sepsis: consequences for immunomonitoring and treatment. Neth J Med. 1999;55:132-141. Medline. doi:10.1016/S0300-2977(98)00156-9
7. Caille V, Chiche J-D, Nciri N, et al. Histocompatibility leukocyte antigen-D related expression is specifically altered and predicts mortality in septic shock but not other causes of shock. Shock. 2004;22:521-526. Medline. doi:10.1097/01.shk.0000143410.63698.57
8. Monneret G, Venet F, Pachot A, Lepage A. Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med. 2008;14:64-78. Medline. doi:10.2119/2007-00102.Monneret
9. Strohmeyer J-C, Blume C, Meisel C, et al. Standardized immune monitoring for the prediction of infections after cardiopulmonary bypass surgery in risk patients. Clinical Cytometry. 2003;53B:54-62. doi:10.1002/cyto.b.10031
10. Oczenski W, Krenn H, Jilch R, et al. HLA-DR as a marker for increased risk for systemic inflammation and septic complications after cardiac surgery. Intensive Care Med. 2003;29:1253-1257. Medline. doi:10.1007/s00134-003-1826-8
11. Franke A, Lante W, Zoeller LG, Kurig E, Weinhold C, Markewitz A. Delayed recovery of human leukocyte antigen-DR expression after cardiac surgery with early non-lethal postoperative complications: only an epiphenomenon? Interact Cardiovasc Thorac Surg. 2008;7:207-211. Medline. doi:10.1510/icvts.2007.158899
12. Lukaszewicz A-C, Grienay M, Resche-Rigon M, et al. Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction. Crit Care Med. 2009;37:2746-2752. Medline. doi:10.1097/CCM.0b013e3181ab858a
13. Hiesmayr MJ, Spittler A, Lassnigg A, et al. Alterations in the number of circulating leucocytes, phenotype of monocyte and cytokine production in patients undergoing cardiothoracic surgery. Clin Exp Immunol. 1999;115:315-323. Medline. doi:10.1046/j.1365-2249.1999.00801.x
14. Sbrana S, Parri MS, De Filippis R, Gianetti J, Clerico A. Monitoring of monocyte functional state after extracorporeal circulation: a flow cytometry study. Clinical Cytometry. 2004;58B:17-24. doi:10.1002/cyto.b.10061
15. Possamai LA, Antoniades CG, Anstee QM, et al. Role ofmonocyte and macrophages in experimental and human acute liver failure. World J Gastroenterol. 2010;16:1811-1819. Medline. doi:10.3748/wjg.v16.i15.1811
16. Xing T, Li L, Cao H, Huang J. Altered immune function of monocytes in different stages of patients with acute and chronic liver failure. Clin Exp Immunol. 2006;147:184-188.
17. Sponholz C, Sakr Y, Brunkhorst F. Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature. Crit Care. 2006; 10: R145.
18. Kirsch M, Vermes E, Radu C, et al. Impact of preoperative hemodynamic support on early outcome in patients assisted with paracorporeal Thoratec ventricular assist device. Eur J Cardiothorac Surg. 2008;34:262-267. Medline. doi:10.1016/j.ejcts.2008.03.057
19. Hochman JS. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation. 2003;107:2998-3002. Medline. doi:10.1161/01.CIR.0000075927.67673.F2
20. Mekontso-Dessap A, Houel R, Soustelle C, Kirsch M, Thébert D, Loisance D. Risk factors for post-cardiopulmonarybypass vasoplegia in patients with preserved left ventricular function. Ann Thorac Surg. 2001;71:1428-1432. Medline. doi:10.1016/S0003-4975(01)02486-9
21. Turina M, Dickinson A, Gardner S, Polk HC. Monocyte HLADR and interferon-gamma treatment in severely injured patients: a critical reappraisal more than a decade later. J Am Coll Surg. 2006;203:73-81. Medline. doi:10.1016/j.jamcollsurg.2006.03.010